Table 2 Characteristics of patients with persistent disease according to the tumor burden
Very small-volume PD (n = 24) | Small-volume PD (n = 25) | Large-volume PD (n = 58) | p | |
|---|---|---|---|---|
Postoperative ATA risk | <.0001 | |||
LR | 13 (54%) | 5 (20%) | 4 (7%) | |
IR | 11 (46%) | 18 (72%) | 37 (64%) | |
HR | 0 | 2 (8%) | 17 (29%) | |
Preparation modality | 0.007 | |||
THW | 9 (37%) | 14 (56%) | 42 (72%) | |
rhTSH | 15 (63%) | 11 (44%) | 16 (28%) | |
PD site | 0.002 | |||
LN | 9 (38%) | 17 (68%) | 30 (52%) | |
LN + DM | 2 (8%) | 2 (8%) | 8 (14%) | |
DM | 13 (54%) | 6 (24%) | 9 (15%) | |
TB disease | 0 | 0 | 6 (10%) | |
TB disease + DM | 0 | 0 | 5 (9%) | |
RAI and 18FDG status | <.0001 | |||
RAI+/18FDG- or NP | 22a (92%) | 17b (68%) | 16c (27%) | |
RAI+/18FDG+ | 0 | 2 (8%) | 12 (21%) | |
RAI−/18FDG+ | 2 (8%) | 6 (24%) | 23 (40%) | |
RAI−/18FDG- | 0 | 0 | 6 (10%) | |
RAI−/18FDG NP | 0 | 0 | 1 (2%) |